Literature DB >> 27474090

Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications.

Michelle L McClure1, Stephen Barnes2, Jeffrey L Brodsky3, Eric J Sorscher4.   

Abstract

Posttranslational modifications add diversity to protein function. Throughout its life cycle, the cystic fibrosis transmembrane conductance regulator (CFTR) undergoes numerous covalent posttranslational modifications (PTMs), including glycosylation, ubiquitination, sumoylation, phosphorylation, and palmitoylation. These modifications regulate key steps during protein biogenesis, such as protein folding, trafficking, stability, function, and association with protein partners and therefore may serve as targets for therapeutic manipulation. More generally, an improved understanding of molecular mechanisms that underlie CFTR PTMs may suggest novel treatment strategies for CF and perhaps other protein conformational diseases. This review provides a comprehensive summary of co- and posttranslational CFTR modifications and their significance with regard to protein biogenesis.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  cystic fibrosis; glycosylation; palmitoylation; phosphorylation; protein trafficking; ubiquitination

Mesh:

Substances:

Year:  2016        PMID: 27474090      PMCID: PMC5142128          DOI: 10.1152/ajplung.00431.2015

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  208 in total

1.  EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin.

Authors:  Yukako Oda; Nobuko Hosokawa; Ikuo Wada; Kazuhiro Nagata
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

2.  Carbohydrate- and conformation-dependent cargo capture for ER-exit.

Authors:  Christian Appenzeller-Herzog; Beat Nyfeler; Peter Burkhard; Inigo Santamaria; Carlos Lopez-Otin; Hans-Peter Hauri
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

3.  Palmitoylation and membrane association of the stress axis regulated insert (STREX) controls BK channel regulation by protein kinase C.

Authors:  Xiaobo Zhou; Iris Wulfsen; Michael Korth; Heather McClafferty; Robert Lukowski; Michael J Shipston; Peter Ruth; Dobromir Dobrev; Thomas Wieland
Journal:  J Biol Chem       Date:  2012-07-29       Impact factor: 5.157

4.  Endoplasmic reticulum (ER)-associated degradation of misfolded N-linked glycoproteins is suppressed upon inhibition of ER mannosidase I.

Authors:  F Tokunaga; C Brostrom; T Koide; P Arvan
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

Review 5.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

6.  Role of individual R domain phosphorylation sites in CFTR regulation by protein kinase A.

Authors:  Tamás Hegedus; Andrei Aleksandrov; April Mengos; Liying Cui; Timothy J Jensen; John R Riordan
Journal:  Biochim Biophys Acta       Date:  2009-03-26

Review 7.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR.

Authors:  Kate J Treharne; Zhe Xu; Jeng-Haur Chen; O Giles Best; Diane M Cassidy; Dieter C Gruenert; Péter Hegyi; Michael A Gray; David N Sheppard; Karl Kunzelmann; Anil Mehta
Journal:  Cell Physiol Biochem       Date:  2009-11-04

9.  GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs.

Authors:  Qi Zhao; Yubin Xie; Yueyuan Zheng; Shuai Jiang; Wenzhong Liu; Weiping Mu; Zexian Liu; Yong Zhao; Yu Xue; Jian Ren
Journal:  Nucleic Acids Res       Date:  2014-05-31       Impact factor: 16.971

10.  A Novel Peptide-Based SILAC Method to Identify the Posttranslational Modifications Provides Evidence for Unconventional Ubiquitination in the ER-Associated Degradation Pathway.

Authors:  Veronica G Anania; Daisy J Bustos; Jennie R Lill; Donald S Kirkpatrick; Laurent Coscoy
Journal:  Int J Proteomics       Date:  2013-02-03
View more
  18 in total

1.  Characterization of Δ(G970-T1122)-CFTR, the most frequent CFTR mutant identified in Japanese cystic fibrosis patients.

Authors:  Kanako Wakabayashi-Nakao; Yingchun Yu; Miyuki Nakakuki; Tzyh-Chang Hwang; Hiroshi Ishiguro; Yoshiro Sohma
Journal:  J Physiol Sci       Date:  2018-06-27       Impact factor: 2.781

2.  Therapeutic attenuation of the epithelial sodium channel with a SPLUNC1-derived peptide in airway diseases.

Authors:  James F Collawn; Rafal Bartoszewski; Ahmad Lazrak; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

3.  A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease.

Authors:  Darren M Hutt; Salvatore Loguercio; Alexandre Rosa Campos; William E Balch
Journal:  J Mol Biol       Date:  2018-06-18       Impact factor: 5.469

Review 4.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

5.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

6.  Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.

Authors:  Darren M Hutt; Salvatore Loguercio; Daniela Martino Roth; Andrew I Su; William E Balch
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

Review 7.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

8.  Features of reactive cysteines discovered through computation: from kinase inhibition to enrichment around protein degrons.

Authors:  Nicholas J Fowler; Christopher F Blanford; Sam P de Visser; Jim Warwicker
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

9.  Skin Biomarkers for Cystic Fibrosis: A Potential Non-Invasive Approach for Patient Screening.

Authors:  Cibele Zanardi Esteves; Letícia de Aguiar Dias; Estela de Oliveira Lima; Diogo Noin de Oliveira; Carlos Fernando Odir Rodrigues Melo; Jeany Delafiori; Carla Cristina Souza Gomez; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Carlos Emílio Levy; Rodrigo Ramos Catharino
Journal:  Front Pediatr       Date:  2018-01-10       Impact factor: 3.418

Review 10.  Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients.

Authors:  Makoto Ono; Don E Burgess; Elizabeth A Schroder; Claude S Elayi; Corey L Anderson; Craig T January; Bin Sun; Kalyan Immadisetty; Peter M Kekenes-Huskey; Brian P Delisle
Journal:  Biomolecules       Date:  2020-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.